Woo-Young Chung
Overview
Explore the profile of Woo-Young Chung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
1305
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Joh H, Lee S, Jo J, Kim H, Lim W, Kim H, et al.
Rev Esp Cardiol (Engl Ed)
. 2024 Apr;
77(12):995-1007.
PMID: 38609042
Introduction And Objectives: There are no clinical data on the efficacy of intravascular imaging-guided percutaneous coronary intervention (PCI) compared with angiography-guided PCI in patients with acute myocardial infarction (AMI) and...
2.
Geum M, Yu Y, Jeon J, Lee H, Shin J, Chung W, et al.
Thromb Res
. 2023 Dec;
233:127-134.
PMID: 38041878
Introduction: The efficacy of intracoronary (IC) antithrombotic therapy, which may best prevent the no-reflow phenomenon during percutaneous coronary intervention (PCI), remains unclear. Therefore, we compared the efficacy and safety of...
3.
Kim N, Chung W, Cho J
Heart Fail Rev
. 2023 Oct;
28(6):1437-1453.
PMID: 37796408
Cardiovascular disease (CVD) has reached epidemic proportions and is a leading cause of death worldwide. One of the long-standing goals of scientists is to repair heart tissue damaged by various...
4.
Kang S, Kim S, Kim S, Chun E, Chung W, Yoon C, et al.
J Korean Med Sci
. 2023 Aug;
38(32):e254.
PMID: 37582501
Background: Fractional flow reserve (FFR) based on computed tomography (CT) has been shown to better identify ischemia-causing coronary stenosis. However, this current technology requires high computational power, which inhibits its...
5.
Hahn J, Jeon J, Geum M, Lee H, Shin J, Chung W, et al.
Thromb J
. 2023 Jul;
21(1):76.
PMID: 37452333
Background: Intracoronary (IC) administration of glycoprotein IIb/IIIa inhibitors (GPIs) has been studied as an adjunctive therapy to improve outcomes in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary...
6.
Kim H, Lim W, Seo J, Chung W
Sci Rep
. 2023 Jan;
13(1):125.
PMID: 36599885
Given the high prevalence and poor prognosis of heart failure (HF), finding prognostic factors for patients with HF is crucial. This study investigated the prognostic value of reactive hyperemia index...
7.
Chung J, Lim W, Seo J, Chung W
AsiaIntervention
. 2022 Dec;
4(2):77-86.
PMID: 36483998
Aims: The purpose of this study was to compare the long-term outcomes of a biodegradable polymer, sirolimus-eluting stent (Orsiro) with a durable polymer, sirolimus-eluting stent (CYPHER) to determine if late...
8.
Jin U, Seo K, Yang H, Lim H, Choi B, Choi S, et al.
J Invasive Cardiol
. 2022 Jul;
34(9):E653-E659.
PMID: 35863061
Background: The optimal duration of dual-antiplatelet therapy (DAPT) after implantation of a drug-eluting stent (DES), especially recently developed polymer-free DESs, is unknown. This study examined the efficacy and safety of...
9.
Chae K, Kim M, Kim B, Jung C, Kang H, Oh D, et al.
Int J Environ Res Public Health
. 2022 Mar;
19(6).
PMID: 35328856
Public reporting is a way to promote quality of healthcare. However, evidence supporting improved quality of care using public reporting in patients with acute myocardial infarction (AMI) is disputed. This...
10.
Choi J, No J, Lee J, Choi S, Chung W, Ah Y, et al.
Cardiovasc Drugs Ther
. 2021 Mar;
36(2):333-345.
PMID: 33725229
Purpose: Although clinically driven low-dose (CDLD) treatment with direct oral anticoagulants (DOACs) is frequently administered to Asian patients with atrial fibrillation, clinical evidence confirming its efficacy remains insufficient. We evaluated...